← European Medicine Shortage Tracker · all medicines

Insuline glargine ((bactérie/escherichia coli)) shortage — availability across Europe

Insuline glargine ((bactérie/escherichia coli)) currently has availability issues reported in 1 European register: France.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Limited availability  ATC — · also listed as: insuline glargine ((bactérie/escherichia coli)) · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Insuline glargine ((bactérie/escherichia coli)), covering 2 affected product presentations.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇫🇷 FranceLimited availability
Lantus 100 unités/ ml, solution injectable en cartouche
+ 2 more products
Toujeo 300 unités/ml DoubleStar, solution injectable en stylo prérempli
Toujeo 300 unités/ml SoloStar, solution injectable en stylo prérempli
2026-05-15Endocrinologieregister ↗

Full report history (3 register entries)

Every individual register entry for Insuline glargine ((bactérie/escherichia coli)) in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇫🇷 FRLantus 100 unités/ ml, solution injectable en cartoucheLimited availabilityEndocrinologie
🇫🇷 FRToujeo 300 unités/ml DoubleStar, solution injectable en stylo préremplResolved2026-05-15Endocrinologie
🇫🇷 FRToujeo 300 unités/ml SoloStar, solution injectable en stylo prérempliLimited availabilityEndocrinologie

Frequently asked

Is Insuline glargine ((bactérie/escherichia coli)) currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: France. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this Insuline glargine ((bactérie/escherichia coli)) availability data come from?

Directly from the official medicines-agency register that lists Insuline glargine ((bactérie/escherichia coli)): ANSM (France). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Insuline glargine ((bactérie/escherichia coli)) — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/insuline-glargine-bacterie-escherichia-coli/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Insuline glargine ((bactérie/escherichia coli)) availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/insuline-glargine-bacterie-escherichia-coli/">Insuline glargine ((bactérie/escherichia coli)) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Insuline glargine ((bactérie/escherichia coli)): availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.